Xuebiao Yao to Kidney Neoplasms
This is a "connection" page, showing publications Xuebiao Yao has written about Kidney Neoplasms.
Connection Strength
0.838
-
Wang F, Wang LS, Gao YH, Yao XD. VHL enhances 9-cis-retinoic acid treatment by down-regulating retinoid X receptor a in renal cell carcinomas. Biochem Biophys Res Commun. 2020 03 05; 523(2):535-541.
Score: 0.603
-
Li W, Yang FQ, Sun CM, Huang JH, Zhang HM, Li X, Wang GC, Zhang N, Che JP, Zhang WT, Yan Y, Yao XD, Peng B, Zheng JH, Liu M. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma. Theranostics. 2020; 10(10):4395-4409.
Score: 0.153
-
Zhang HL, Zhu Y, Wang CF, Yao XD, Zhang SL, Dai B, Shen YJ, Zhu YP, Shi GH, Ye DW. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol. 2011 Jun; 18(6):422-30.
Score: 0.082